Recent advances in the epidemiology and genetics of acute intermittent porphyria

被引:16
作者
Ma, Liyan [1 ]
Tian, Yu [1 ]
Peng, Chenxing [1 ]
Zhang, Yiran [2 ]
Zhang, Songyun [1 ]
机构
[1] Hebei Med Univ, Dept Endocrinol, Hosp 2, Shijiazhuang, Hebei, Peoples R China
[2] Southern Med Univ, Clin Med Coll 1, Guangzhou, Guangdong, Peoples R China
关键词
acute intermittent porphyria; prevalence; penetrance; genetic traits; genotype-phenotype correlation; modifying genes; PORPHOBILINOGEN DEAMINASE GENE; ACTIVATED RECEPTOR-ALPHA; HYDROXYMETHYLBILANE SYNTHASE MUTATIONS; REVERSIBLE ENCEPHALOPATHY SYNDROME; HEPATIC HEME-BIOSYNTHESIS; 5-AMINOLEVULINIC ACID; HMBS GENE; CLINICAL EXPRESSION; MOLECULAR ANALYSIS; HIGH PREVALENCE;
D O I
10.5582/irdr.2020.03082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute intermittent porphyria (AIP) is a dominant inherited disorder with a low penetrance that is caused by mutations in the gene coding for hydroxymethylbilane synthase (HMBS). Information about the epidemiology and molecular genetic features of this rare disorder is crucial to clinical research, and particularly to the evaluation of new treatments. Variations in the prevalence and penetrance of AIP in various studies may due to the different inclusion criteria and methods of assessment. Here, the prevalence and penetrance of AIP are analyzed systematically, and the genetic traits of different populations and findings regarding the genotype-phenotype correlation are summarized. In addition, quite a few studies have indicated that AIP susceptibility was affected by other factors, such as modifying genes. Findings regarding possible modifying genes are documented here, helping to reveal the pathogenesis of and treatments for AIP. The status of research on AIP in China reveals the lack of epidemiological and genetic studies of the Chinese population, a situation that needs to be promptly remedied.
引用
收藏
页码:196 / 204
页数:9
相关论文
共 121 条
[1]   STUDIES IN PORPHYRIA .8. RELATIONSHIP OF THE 5-ALPHA-REDUCTIVE METABOLISM OF STEROID-HORMONES TO CLINICAL EXPRESSION OF THE GENETIC DEFECT IN ACUTE INTERMITTENT PORPHYRIA [J].
ANDERSON, KE ;
BRADLOW, HL ;
SASSA, S ;
KAPPAS, A .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (04) :644-650
[2]  
Anderson KE., 2001, Metabolic and molecular basis of inherited disease, V8 th, P2991
[3]   Acute intermittent porphyria in women:: clinical expression, use and experience of exogenous sex hormones.: A population-based study in northern Sweden [J].
Andersson, C ;
Innala, E ;
Bäckström, T .
JOURNAL OF INTERNAL MEDICINE, 2003, 254 (02) :176-183
[4]  
Andersson C, 2000, SCAND J CLIN LAB INV, V60, P643
[5]   Hepatic porphyria: A narrative review [J].
Arora S. ;
Young S. ;
Kodali S. ;
Singal A.K. .
Indian Journal of Gastroenterology, 2016, 35 (6) :405-418
[6]   Molecular mechanisms of dominant expression in porphyria [J].
Badminton, MN ;
Elder, GH .
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (03) :277-286
[7]   Genomic and non-genomic interactions of PPARα with xenobiotic-metabolizing enzymes [J].
Barbier, O ;
Fontaine, C ;
Fruchart, JC ;
Staels, B .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (07) :324-330
[8]   High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor [J].
Barreda-Sanchez, Maria ;
Buendia-Martinez, Juan ;
Glover-Lopez, Guillermo ;
Carazo-Diaz, Carmen ;
Juliana Ballesta-Martinez, Maria ;
Lopez-Gonzalez, Vanesa ;
Jose Sanchez-Soler, Maria ;
Rodriguez-Pena, Lidya ;
Teresa Serrano-Anton, Ana ;
Gil-Ferrer, Remedios ;
Del Carmen Martinez-Romero, Maria ;
Carbonell-Meseguer, Pablo ;
Guillen-Navarro, Encarna .
ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
[9]   Penetrance and predictive value of genetic screening in acute porphyria [J].
Baumann, K. ;
Kauppinen, R. .
MOLECULAR GENETICS AND METABOLISM, 2020, 130 (01) :87-99
[10]   ACUTE PORPHYRIAS [J].
Besur, Siddesh ;
Schmeltzer, Paul ;
Bonkovsky, Herbert L. .
JOURNAL OF EMERGENCY MEDICINE, 2015, 49 (03) :305-312